Implementing the Breast Health Global Initiative guidelines
Prof Benjamin Anderson
Implementing the Breast Health Global Initiative guidelines ( Prof Benjamin Anderson )
12 Jul 2019
Guidelines for prepectoral implant-based breast reconstruction
Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK
Guidelines for prepectoral implant-based breast reconstruction ( Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK )
11 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast ...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast canc...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
18 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with ot...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
The potential of PARP inhibitors in new cancer groups and in combination with other treatments ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-m...
Prof Hope Rugo - University of California, San Francisco, USA
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-mutated/HR /HER2- advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
12 Jun 2019
Advances in PARP inhibitor use for metastatic breast cancer
Prof Hope Rugo - University of California, San Francisco, USA
Advances in PARP inhibitor use for metastatic breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
12 Jun 2019
Margetuximab for the treatment of HER2-positive breast cancer
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston,...
Margetuximab for the treatment of HER2-positive breast cancer ( Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston, USA )
12 Jun 2019
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced tr...
Dr Tira Tan - National Cancer Centre, Singapore
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer ( Dr Tira Tan - National Cancer Centre, Singapore )
12 Jun 2019
EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients...
Dr Johannes Ettl - Technical University, Munich, Germany
EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients with advanced breast cancer ( Dr Johannes Ettl - Technical University, Munich, Germany )
12 Jun 2019
Ribociclib plus endocrine therapy improves survival in premenopausal patients wi...
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston,...
Ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic breast cancer ( Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Jun 2019